Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.36
-0.13 (-0.40%)
Dec 3, 2024, 1:53 PM EST - Market open
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.62 billion as of December 3, 2024. Its market cap has decreased by -30.16% in one year.
Market Cap
1.62B
Enterprise Value
1.21B
1-Year Change
-30.16%
Ranking
Category
Stock Price
$32.36
Market Cap Chart
Since the IPO on February 5, 2021, Immunocore Holdings's market cap has increased from $1.08B to $1.62B, an increase of 49.27%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 1.63B | -51.87% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | 38.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynavax Technologies | 1.69B |
| Spyre Therapeutics | 1.67B |
| InMode | 1.65B |
| Evotec SE | 1.65B |
| Schrödinger | 1.64B |
| Travere Therapeutics | 1.64B |
| Neumora Therapeutics | 1.61B |
| Kiniksa Pharmaceuticals International, | 1.59B |